Rob LubowNews

Nick Deeter joins Botcopy's Board of Directors

Botcopy Welcomes Visionary Leader Nick Deeter to Board of Directors

Santa Monica, CA – June 4, 2024 – Botcopy, an award-winning Google Cloud SaaS & Service Partner and leader in AI-driven web chat interfaces for secure government and enterprise solutions, welcomes Nick Deeter as its newest Board of Directors member.

Botcopy, recognized with the Google Next Award 2023, is known for integrating Google's generative AI and CCAI into secure, multilingual, and ADA-compliant digital platforms. The company's impressive track record includes engagements with notable entities such as the State of Minnesota, the City of New York Department of Health, Shriners Children's Hospitals, Century 21, and Dexcom, reflecting its strong reputation in delivering advanced AI solutions to diverse sectors.

As Botcopy continues to revolutionize its innovative solutions across public, healthcare, and enterprise sectors, Mr. Deeter's extensive experience in healthcare technology and entrepreneurship promises to bring valuable insights and leadership to the company.

Nick Deeter, a true pioneer in medical technology, embarked on his career at Zimmer Biomet, Inc., and swiftly ascended to leadership roles at DePuy Synthes, a Johnson & Johnson Co., and Medical Ventures Ltd. Mr. Deeter led the technology transfer office at Case Western Reserve University, commercializing hundreds of millions of dollars of basic and applied research yearly.  He founded OrthoPediatrics Corp., a groundbreaking company in pediatric orthopedics, now publicly traded as KIDS. He established WishBone Medical, introducing revolutionary sterile orthopedic implant kits for children, a testament to his transformative contributions.

Mr. Deeter's career is marked by numerous accolades, including E&Y Midwest Entrepreneur of the Year in 2020 and titles such as "Undisputed Pioneer of Pediatric Orthopedics" from OrthoStream. His ventures extend beyond healthcare, demonstrating a broad impact across various industries.

"Nick's visionary leadership and profound impact on healthcare technology make him an invaluable asset to our team," said Dustin Dye, CEO of Botcopy. "His innovative spirit perfectly matches Botcopy's mission to advance AI communication technologies."

Mr. Deeter expressed his enthusiasm about joining Botcopy, stating, "I'm thrilled to contribute to a company that leads in AI technology, enhancing public and enterprise interactions significantly."

With Nick Deeter's guidance, Botcopy is set to further its impact, effectively pioneering and improving AI communications across various sectors.

For more information about Botcopy and its services, please visit